{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:06:34Z","timestamp":1773713194089,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4439,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.fertnstert.2009.02.059","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T05:06:22Z","timestamp":1238648782000},"page":"2042-2047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro"],"prefix":"10.1016","volume":"93","author":[{"given":"Divya K.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.J.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes M.","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjel","family":"Vahratian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahryar K.","family":"Kavoussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan I.","family":"Lebovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.02.059_bib1","first-page":"111","article-title":"Role of vascular endothelial growth factor in ovarian physiology\u2014an overview","volume":"5","author":"Kaczmarek","year":"2005","journal-title":"Reprod Biol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib3","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/humrep\/12.12.2756","article-title":"Vascular endothelial growth factor production by human luteinized granulosa cells in vitro","volume":"12","author":"Lee","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib4","first-page":"157","article-title":"Expression of VPF\/VEGF by human granulosa and theca lutein cells: role in corpus luteum development","volume":"146","author":"Kamat","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI200318740","article-title":"Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development","volume":"112","author":"Zimmermann","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/humrep\/del427","article-title":"Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF","volume":"3","author":"Manau","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0015-0282(98)00447-6","article-title":"Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries","volume":"71","author":"Agrawal","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.cellbio.12.1.335","article-title":"Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology","volume":"12","author":"Lemberger","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1677\/joe.1.06667","article-title":"Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition","volume":"189","author":"Froment","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1477-7827-3-41","article-title":"Peroxisome proliferator-activated receptors (PPARs) and ovarian function\u2014implications for regulating steroidogenesis, differentiation, and tissue remodeling","volume":"3","author":"Komar","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0215634","article-title":"PPAR gamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis","volume":"110","author":"Panigrahy","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10456-005-9027-4","article-title":"PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis","volume":"8","author":"Peeters","year":"2005","journal-title":"Angiogenesis"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib13","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2005-2739","article-title":"The role of luteinizing hormone\/human chorionic gonadotropin receptor-specific mRNA binding protein in regulating receptor expression human ovarian granulosa cells","volume":"91","author":"Nair","year":"2006","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fertnstert.2006.01.046","article-title":"Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures","volume":"86","author":"Asimakopoulos","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(01)00907-4","article-title":"Binding of prostaglandins to human PPAR\u03b3: tool assessment and new natural ligands","volume":"417","author":"Ferry","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib16","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.1074\/jbc.274.13.9116","article-title":"Peroxisome proliferators-activated receptor-\u03b3 ligands are potent inhibitors of angiogenesisin vitroand in vivo","volume":"274","author":"Xin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","article-title":"Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome","volume":"344","author":"McClure","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib18","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/en.2002-220204","article-title":"Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rates, and this effect is prevented by receptor blockage","volume":"143","author":"G\u00f3mez","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib19","first-page":"421a","article-title":"Hypoxia stimulates expression of the gene for vascular endothelial growth factor (VEGF), a putative angiogenic factor, by granulosa cells of the ovarian follicle, a site of angiogenesis","volume":"115","author":"Koos","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/09513599709152564","article-title":"Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary","volume":"11","author":"Yamamoto","year":"1997","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib21","first-page":"1967","article-title":"Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome","volume":"80","author":"Neulen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/humrep\/dem042","article-title":"Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome","volume":"22","author":"Kosaka","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/humrep\/dem429","article-title":"Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome","volume":"23","author":"Villasante","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endoethelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejogrb.2005.01.009","article-title":"Cabergoline: a safe, easy, cheap, and effective drug for prevention\/treatment of ovarian hyperstimulation syndrome","volume":"122","author":"Manno","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib26","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1210\/en.2006-0657","article-title":"Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEG-F)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent lutueal angiogenesis in a rat ovarian hyperstimulation model","volume":"147","author":"G\u00f3mez","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib27","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"Alvarez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib28","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular evenets in patients with type 2 diabetes mellitus","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib30","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/dmrr.252","article-title":"Differentiating members of the thiazolidinedione class: a focus on safety","volume":"18","author":"Lebovitz","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/dmrr.253","article-title":"Are all glitazones the same?","volume":"18","author":"Van Gaal","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib32","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.fertnstert.2006.03.024","article-title":"An in vivo murine model of rosiglitazone use in pregnancy","volume":"86","author":"Klinker","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib33","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1210\/en.2007-1570","article-title":"Peroxisome proliferators-activated receptor-\u03b3 agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality","volume":"149","author":"Minge","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2009.02.059_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.reprotox.2008.08.001","article-title":"Case series of rosiglitazone used during the first trimester of pregnancy","volume":"26","author":"Haddad","year":"2008","journal-title":"Reprod Toxicol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209004786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209004786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:39:22Z","timestamp":1758008362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209004786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0015028209004786"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.059","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}